A carregar...
Bispecific antibodies and CARs: generalized immunotherapeutics harnessing T cell redirection
To realize the full potential of cancer immunotherapy, the latest generation immunotherapeutics are designed to harness the potent tumor-killing capacity of T cells. Thus, to mobilize T cells, new optimized bispecific antibody (BsAb) designs, enabling efficient polyclonal redirection of cytotoxic ac...
Na minha lista:
| Publicado no: | Curr Opin Immunol |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4884546/ https://ncbi.nlm.nih.gov/pubmed/26963133 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.coi.2016.02.006 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|